RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
45 hedge funds and large institutions have $147M invested in Regulus Therapeutics in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
73% more funds holding
Funds holding: 26 → 45 (+19)
24.59% more ownership
Funds ownership: 54.97% → 79.56% (+25%)
Holders
45
Holding in Top 10
2
Calls
$1.11M
Puts
$163K
Top Buyers
| 1 | +$24M | |
| 2 | +$18M | |
| 3 | +$14.4M | |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$13M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10.6M |
Top Sellers
| 1 | -$117K | |
| 2 | -$36.4K | |
| 3 | -$449 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$121 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$14 |